| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy
|
Kotaka, Masahito
|
|
|
86 |
5 |
p. 607-618
|
artikel
|
| 2 |
A preliminary assessment of oral monepantel’s tolerability and pharmacokinetics in individuals with treatment-refractory solid tumors
|
Mislang, Anna
|
|
|
86 |
5 |
p. 589-594
|
artikel
|
| 3 |
Assessment of acute kidney injury related to small-molecule protein kinase inhibitors using the FDA adverse event reporting system
|
Fan, Qianqian
|
|
|
86 |
5 |
p. 655-662
|
artikel
|
| 4 |
Beta-adrenergic blocker inhibits oral carcinogenesis and reduces tumor invasion
|
Cecilio, Heitor Pinhata
|
|
|
86 |
5 |
p. 681-686
|
artikel
|
| 5 |
Combination efficacy of pertuzumab and trastuzumab for trastuzumab emtansine-resistant cells exhibiting attenuated lysosomal trafficking or efflux pumps upregulation
|
Yamashita-Kashima, Yoriko
|
|
|
86 |
5 |
p. 641-654
|
artikel
|
| 6 |
Comparative efficacy and safety of trastuzumab biosimilars to the reference drug: a systematic review and meta-analysis of randomized clinical trials
|
Cargnin, Sarah
|
|
|
86 |
5 |
p. 577-588
|
artikel
|
| 7 |
Efficacy and safety of oral magnesium supplementation in reducing febrile neutropenia episodes in children with solid tumors treated with cisplatin-based chemotherapy: randomized clinical trial
|
Castelán-Martínez, Osvaldo D.
|
|
|
86 |
5 |
p. 673-679
|
artikel
|
| 8 |
In vitro evaluation of the metabolic enzymes and drug interaction potential of triapine
|
Joshi, Anand
|
|
|
86 |
5 |
p. 633-640
|
artikel
|
| 9 |
Physiologically based pharmacokinetic modeling and simulation to predict drug–drug interactions of ivosidenib with CYP3A perpetrators in patients with acute myeloid leukemia
|
Prakash, Chandra
|
|
|
86 |
5 |
p. 619-632
|
artikel
|
| 10 |
Population pharmacokinetic analysis of phase 1 bemarituzumab data to support phase 2 gastroesophageal adenocarcinoma FIGHT trial
|
Xiang, Hong
|
|
|
86 |
5 |
p. 595-606
|
artikel
|
| 11 |
Slower degradation rate of cytarabine in blood samples from acute myeloid leukemia by comparison with control samples
|
Abbara, Chadi
|
|
|
86 |
5 |
p. 687-691
|
artikel
|
| 12 |
Successful management of hyperammonemia withhemodialysis on day 2 during 5-fluorouracil treatment in a patient with gastric cancer: acase report with 5-fluorouracil metabolite analyses
|
Ozaki, Yoshinao
|
|
|
86 |
5 |
p. 693-699
|
artikel
|
| 13 |
Targeting MALAT1 induces DNA damage and sensitize non-small cell lung cancer cells to cisplatin by repressing BRCA1
|
Huang, Jinghua
|
|
|
86 |
5 |
p. 663-672
|
artikel
|
Tijdschrift beschrijving